PVLA
Palvella Therapeutics
PVLA
PVLA
96 hedge funds and large institutions have $107M invested in Palvella Therapeutics in 2020 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 26 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.01% less ownership
Funds ownership: 0.84% → 0.82% (-0.01%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
96
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
1 | +$2.66M | |
2 | +$1.97M | |
3 | +$1.57M | |
4 |
BlackRock
New York
|
+$659K |
5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$635K |
Top Sellers
1 | -$8.55M | |
2 | -$4.69M | |
3 | -$1.04M | |
4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$602K |
5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$440K |